AEGIS VOPAK TERMINALS Q2 FY27

Net Profit: ₹96 Cr ↓4% YoY | ↑39% QoQ

Revenue: ₹271 Cr ↑17% YoY | ↑16% QoQ

EBITDA: ₹212 Cr ↑22% YoY | ↑18% QoQ

EBITDA Margin: 78.4% vs 74.7% YoY | 76.8% QoQ

ITC HOTELS Q2 FY27 (CONS.)

Net Profit: ₹202.65 Cr ↑52.04% YoY | ↑11.40% QoQ

Revenue: ₹1,054.14 Cr ↑25.57% YoY | ↑12.62% QoQ

EBITDA: ₹337.45 Cr ↑37.31% YoY | ↑15.44% QoQ

EBITDA Margin: 32.01% vs 29.27% YoY | 31.23% QoQ

SURANA SOLAR Q2 FY27

Net Profit: ₹1 Cr ↑39% YoY | ↓86% QoQ

Revenue: ₹10 Cr ↑297% YoY | ↓40% QoQ

EBITDA: ₹1 Cr vs ₹2 Cr loss YoY | ↑81% QoQ

EBITDA Margin: 10.1% vs -90.3% YoY | 3.3% QoQ

SHANTHI GEARS Q2 FY27 (STANDALONE)

Net Profit: ₹16 Cr ↓27% YoY | ↑59% QoQ

Revenue: ₹128 Cr ↓3% YoY | ↑11% QoQ

Other Income: ₹3 Cr vs ₹6 Cr YoY | ₹4 Cr QoQ

Operating Profit: ₹23 Cr ↓14% YoY | ↑50% QoQ

Operating Profit Margin: 17.7% vs 20.1% YoY | 13.1% QoQ

EPS: ₹2.05 ↓27% YoY | ↑60% QoQ

VINYL CHEMICALS Q2 FY27

Net Profit: ₹11.41 Cr ↑296.18% YoY | ↑72.36% QoQ

Revenue: ₹218.57 Cr ↑43.90% YoY | ↑119.36% QoQ

EBITDA: ₹16.70 Cr ↑525.47% YoY | ↑523.13% QoQ

EBITDA Margin: 7.64% vs 1.76% YoY | 2.69% QoQ

MACPOWER CNC Q2 FY27 (STANDALONE)

Net Profit: ₹13 Cr ↑44% YoY | ↑41% QoQ

Revenue: ₹120 Cr ↑40% YoY | ↑26% QoQ

Other Income: ₹0 Cr vs ₹0 Cr YoY | ₹0 Cr QoQ

Operating Profit: ₹20 Cr ↑41% YoY | ↑29% QoQ

Operating Profit Margin: 16.6% vs 16.5% YoY | 16.2% QoQ

EPS: ₹13.47 ↑44% YoY | ↑41% QoQ

MANTRA CAPITAL Q2 FY27

Net Profit: ₹1.82 Cr vs ₹3.21 Cr loss YoY | vs ₹3.96 Cr loss QoQ

NII: ₹2.48 Cr ↑45% YoY | ↑7% QoQ

EU PLANS TO HIT CHINA WITH IMPORT CURBS ON CHEMICALS, FURNITURE

Indian Overseas Bank – Q2 FY27 FINANCIAL RESULTS HIGHLIGHTS

Financial results for the quarter and half-year ended 30th September 2026:

- Net Profit for Q2 FY27 increased 55.95% YoY to INR 1912 Cr

- Net Interest Income for Q2 FY27 increased 26.41% YoY to INR 3867 Cr

- Operating Profit for Q2 FY27 increased 25.67% YoY to INR 3016 Cr

- Gross NPA ratio reduced to 1.19% and Net NPA ratio reduced to 0.16%

- Global Business increased 22.05% YoY to INR 753078 Cr

- H1 FY27 Net Profit increased 52.85% YoY to INR 3572 Cr

LUMAX INDUSTRIES Q2 FY27 (CONS.)

Net Profit: ₹51.99 Cr ↑45.87% YoY | ↑1.78% QoQ

Revenue: ₹1,341.84 Cr ↑33.04% YoY | ↑9.70% QoQ

EBITDA: ₹115.62 Cr ↑30.41% YoY | ↑7.32% QoQ

EBITDA Margin: 8.62% vs 8.79% YoY | 8.81% QoQ

SupremeInd Mgmt On CNBC-TV18 Says:

⏩Volume Growth In FY27 Will Be 10%

⏩Overall Volume Growth In FY27 Will Be 10% Vs 12% Guided Earlier

⏩Q3FY27 Has Started On A Strong Footing

⏩Margin Will Hold Around 14-14.5% In FY27

⏩Piping Volume Guidance Expected At 13% In FY27 Vs 15% Earlier

ATHER ENERGY Q2 FY27 (STANDALONE)

Net Profit: ₹4 Cr vs ₹157 Cr loss YoY | vs ₹51 Cr loss QoQ

Revenue: ₹1,464 Cr ↑63% YoY | ↑20% QoQ

Other Income: ₹63 Cr vs ₹42 Cr YoY | ₹43 Cr QoQ

EPS: ₹0.04 vs -₹4.11 YoY | -₹1.33 QoQ

SRM CONTRACTORS LIMITED: CO. BAGS CONTRACT WORTH ₹138.37 CRORES FROM MORTH FOR LANDSLIDE TREATMENT ON NH-09; CONTRACT TO BE EXECUTED IN 18 MONTHS.

JBMA: Q2 CONS NET PROFIT 586M RUPEES VS 526M (YOY)

JBMA: Q2 EBITDA 1.9B RUPEES VS 1.55B (YOY); Q2 EBITDA MARGIN 11.54% VS 11.33% (YOY)

JBMA: Q2 REVENUE 16.6B RUPEES VS 13.7B (YOY)

ATHER ENERGY: BOARD APPROVES EXPANSION OF MANUFACTURING CAPACITY; CAPEX OF ₹122 CRORES ALLOCATED; HOSUR CAPACITY TO INCREASE FROM 420,000 TO 495,000 UNITS; FACTORY 3.0 CAPACITY TO RISE FROM 500,000 TO 650,000 UNITS; COMPLETION EXPECTED BY DECEMBER 2026 AND Q2 FY28

AVANTEL Q2 FY27

Net Profit: ₹7 Cr ↑60% YoY | ↑26% QoQ

Revenue: ₹74 Cr ↑34% YoY | ↑6% QoQ

Other Income: ₹0 Cr vs ₹1 Cr YoY | ₹0 Cr QoQ

Operating Profit: ₹21 Cr ↑84% YoY | ↑20% QoQ

Operating Profit Margin: 28.0% vs 20.4% YoY | 24.8% QoQ

EPS: ₹0.26 ↑73% YoY | ↑30% QoQ

ATHER ENERGY: CO WILL FURTHER EXPAND THE PLANT’S ANNUAL CAPACITY BY 1.5 LAKH UNITS TO 6.5 LAKH UNITS, WITH THE ADDITIONAL CAPACITY EXPECTED TO COMMENCE PRODUCTION BY Q2 FY28

MANKIND PHARMA Q2 FY27

Net Profit: ₹711 Cr ↑39% YoY | ↑25% QoQ

Revenue: ₹4,338 Cr ↑17% YoY | ↑8% QoQ

Other Income: ₹95 Cr vs ₹92 Cr YoY | ₹45 Cr QoQ

EPS: ₹17.23 ↑39% YoY | ↑25% QoQ

MANKIND: Q2 CONS NET PROFIT 7.1B RUPEES VS 5.11B (YOY); EST 6.15B

MANKIND: Q2 EBITDA 11.7B RUPEES VS 9.21B (YOY); Q2 EBITDA MARGIN 27% VS 24.92% (YOY)

MANKIND: Q2 REVENUE 43.4B RUPEES VS 36.97B (YOY)

MILKFOOD Q2 FY27

Net Profit: ₹1 Cr vs ₹8 Cr loss YoY | ↑500% QoQ

Revenue: ₹101 Cr ↑37% YoY | ↑25% QoQ

EBITDA: ₹6 Cr vs ₹2 Cr loss YoY | ↑84% QoQ

EBITDA Margin: 6.3% vs -3.1% YoY | 4.3% QoQ

MANKIND PHARMA Q2 FY27 (CONS.) ; NET PROFIT UP 37.67% AT ₹716.12 CR (YOY), UP 24.74% (QOQ)

REVENUE UP 17.33% AT ₹4,337.86 CR (YOY), UP 7.62% (QOQ)

EBITDA UP 27.13% AT ₹1,171.25 CR (YOY), UP 10.89% (QOQ)

MARGINS AT 27.00% VS 24.92% (YOY), 26.20% (QOQ)